会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • 수분흡수능이 우수한 매트릭스형 경피투여제
    • 具有改进的吸水性能的矩阵式,超导药物递送系统
    • KR1020020035451A
    • 2002-05-11
    • KR1020010068525
    • 2001-11-05
    • 주식회사 삼양홀딩스
    • 송진덕김동원
    • A61K9/70
    • A61K9/7053A61K9/7061A61K31/196A61K47/02A61K47/32
    • PURPOSE: A matrix type, transdermal drug delivery system having improved water-absorbability is provided, which system absorbs sweat well and is easily removed from the skin. CONSTITUTION: The matrix type, transdermal drug delivery system having improved water-absorbability comprises a backing layer(1) protecting a drug, a matrix layer(2) containing an effective drug and a release liner film(3) to be removed before applying the system to the skin, in which the matrix layer(2) contains 1 to 25 wt.% of effective drugs, 40 to 95 wt.% of acryl adhesive, 1 to 7 wt.% of polyvinylpyrrolidone having a molecular weight of 1 million to 500 million, 1 to 13 wt.% of polyvinylpyrrolidone having a molecular weight of 2,000 to 50,000, 0.1 to 25 wt.% of nonionic surfactant as an absorption promoting agent, 0.1 to 10 wt.% of terepene diluent and 0.1 to 10 wt.% of melting-assistant solvent, and further contains 0.5 to 5 wt.% of colloidal silica; and the effective drug is diclofenac diethylammonium.
    • 目的:提供具有改善的吸水性的基质型透皮药物递送系统,该系统很好地吸收汗液,容易从皮肤上去除。 构成:具有改善的吸水性的基质型透皮药物递送系统包括保护药物的背衬层(1),含有有效药物的基质层(2)和待使用的剥离衬垫膜(3) 系统,其中基质层(2)含有1至25重量%的有效药物,40至95重量%的丙烯酸粘合剂,1至7重量%的分子量为100万的聚乙烯吡咯烷酮 5重量%,1〜13重量%的分子量为2,000〜50,000的聚乙烯吡咯烷酮,0.1〜25重量%的作为吸收促进剂的非离子表面活性剂,0.1〜10重量%的泼尼松稀释剂和0.1〜10重量% %的熔融助溶剂,还含有0.5〜5重量%的胶体二氧化硅; 有效药物为双氯芬酸二乙基铵。